All News #Library
Rare Diseases
FDA Rejects Scholar Rock`s Muscle Weakness Drug; Shares Drop
24 Sep 2025 //
REUTERS
Cycle taps into Catalent’s Zydis tech to manufacture four products
01 Nov 2019 //
IN-PHRMATECHNOLOGIST
Cycle Pharmaand Catalent Partner to Develop Treatments for Rare Diseases
31 Oct 2019 //
BUSINESSWIRE

Market Place
Sourcing Support